eCite Digital Repository

The pathophysiological effects of serum copper in type 2 diabetes mellitus with and without diabetic nephropathy

Citation

Al-Bayati, MA and Jamil, DA and Al-Aubaidy, HA, The pathophysiological effects of serum copper in type 2 diabetes mellitus with and without diabetic nephropathy, World Journal of Pharmaceutical Research, 4, (1) pp. 178-187. ISSN 2277-7105 (2015) [Refereed Article]


Preview
PDF
Restricted - Request a copy
415Kb
  

Copyright Statement

Copyright 2015 World Journal of Pharmaceutical Research

Official URL: http://www.wjpr.net/dashboard/archive

Abstract

This study was undertaken to investigate the effects of copper on the development of lipid peroxidation in patients with type 2 diabetes mellitus with and without diabetic nephropathy. Fifty-five patients with type 2 diabetes mellitus were recruited in this study and were divided into 2 sub-groups based on the presence of microalbuminuria, the first group (microalbuminuric group n = 31) had a microalbuminuria between 30-299 ug/mg. The second group (normoalbuminuric group, n = 29) had an albumin level less than 30 ug/mg. The two diabetic groups were compared to the control group (n = 37). The results of our study showed significant elevation in the levels of serum lipid profiles and lipid peroxidation markers in the microalbuminuric group compared to the normoalbuminuric group at P < 0.001. This was associated with significant rise of serum copper in the diabetic group with nephropathy compared to the diabetic group with no nephropathy and the control group, P < 0.001. The current study illustrates that the presence of microalbuminuria in type 2 DM can be regarded as an index of increased cardiovascular vulnerability and a signal for vigorous efforts at correction of known modifiable risk factors in which serum Cu one of them.

Item Details

Item Type:Refereed Article
Keywords:serum copper, lipid peroxidation, microalbuminuria, type 2 diabetes mellitus
Research Division:Medical and Health Sciences
Research Group:Medical Biochemistry and Metabolomics
Research Field:Medical Biochemistry: Carbohydrates
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Diabetes
Author:Al-Aubaidy, HA (Dr Hayder Al-Aubaidy)
ID Code:98713
Year Published:2015
Deposited By:Medicine (Discipline)
Deposited On:2015-02-26
Last Modified:2016-05-10
Downloads:0

Repository Staff Only: item control page